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ropomyosin (Tm) is a key component of the actin cyto-
skeleton and 
 
 
 
40 isoforms have been described in mam-
mals. In addition to the isoforms in the sarcomere, we
now report the existence of two nonsarcomeric (NS) iso-
forms in skeletal muscle. These isoforms are excluded from
the thin ﬁlament of the sarcomere and are localized to a
novel Z-line adjacent structure. Immunostained cross sections
indicate that one Tm deﬁnes a Z-line adjacent structure
common to all myoﬁbers, whereas the second Tm deﬁnes
T
 
a spatially distinct structure unique to muscles that undergo
chronic or repetitive contractions. When a Tm (Tm3) that is
normally absent from muscle was expressed in mice it
became associated with the Z-line adjacent structure. These
mice display a muscular dystrophy and ragged-red ﬁber
phenotype, suggestive of disruption of the membrane-asso-
ciated cytoskeletal network. Our ﬁndings raise the possi-
bility that mutations in these tropomyosin and these struc-
tures may underpin these types of myopathies.
 
Introduction
 
The actin filament system is involved in a large array of
functions that touch almost all aspects of the life of a cell.
These vary from cell movement and cytokinesis to cell sig-
naling and intracellular trafficking. Therefore, it has become
an important challenge to understand how one filament
system can independently regulate such a diverse range of
cellular processes.
The actin filament is a double-stranded helical polymer of
actin, the majority of which contain a tropomyosin polymer
running along the helical groove (Flicker et al., 1982).
Whereas actin is a globular protein that exists as monomer
and polymer, tropomyosin is a rodlike head-to-tail dimer that
is only known to exist in association with actin (Flicker et al.,
1982; Matsumura et al., 1983). Both components, actin and
tropomyosin, have been shown to contribute to the physical
properties of the microfilament (Kojima et al., 1994).
Actin and tropomyosin are encoded by multigene families
and tropomyosin is also subject to extensive alternative splicing
(Herman, 1993; Pittenger et al., 1994). Genetic manipulation
has demonstrated that these isoforms are not redundant but
rather encode different functional information. Cardiac 
 
 
 
-actin
is essential for normal cardiac function (Kumar et al., 1997),
 
 
 
-actin is required for cell spreading and motility (Schevzov
et al., 1992; Kislauskis et al., 1997), and 
 
 
 
-smooth muscle
actin controls the contractility of myofibroblasts (Ronnov-
Jessen and Petersen, 1996). Elevated expression of 
 
 
 
-actin
disrupts stress-like organization in myoblasts (Schevzov et
al., 1992) and sarcomere organization in cardiomyoctes (von
Arx et al., 1995). Similarly, the Tm5NM-1 tropomyosin is
required for melanoma cell motility (Miyado et al., 1996),
 
 
 
-fast tropomyosin is required for normal cardiac function
(Thierfelder et al., 1994; Bottinelli et al., 1998; Muthu-
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chamy et al., 1999), and the Tm1 and Tm2 tropomyosins
are required to restore normal microfilament organization to
cancer cells (Prasad et al., 1993; Boyd et al., 1995; Gimona
et al., 1996). A specific tropomyosin isoform is required for
correct mRNA targeting in 
 
Drosophila
 
 (Erdelyi et al., 1995)
and the 
 
 
 
-TM gene is essential for embryonic development
and embryonic stem cell viability (Hook et al., 2004).
The tropomyosins also show a variety of isoform-specific
protein properties. The strength of binding to actin differs
between tropomyosin isoforms although the original obser-
vation of tighter binding of the larger sized tropomyosins
(Matsumura and Yamashiro-Matsumura, 1985) does not
hold for some specific smaller tropomyosins (Pittenger et al.,
1995). Tropomyosin isoforms also differentially protect ac-
tin filaments from severing by gelsolin (Ishikawa et al.,
1989a,b) and regulate both myosin motor mechanochemis-
try (Fanning et al., 1994) and the sorting of myosin motors
(Bryce et al., 2003). The azimuthal position assumed by tro-
pomyosin on an actin filament also differs between isoforms
and is additionally influenced by the actin isoform (Lehman
et al., 2000). Therefore, it is clear that the properties of actin
filaments are likely to differ depending on both the actin
and tropomyosin isoform composition of the filament.
The extensive sorting of tropomyosin and actin isoforms
to different intracellular locations provides two significant
advantages to the cell (Gunning et al., 1998a,b). On the
one hand, it allows the cell to independently control the
supply of microfilament building blocks to different cellular
sites. On the other hand, it provides a mechanism to regu-
late the functional properties of microfilaments at these sites
(Weinberger et al., 1996; Schevzov et al., 1997; Hannan et
al., 1998; Percival et al., 2000). The majority of these obser-
vations concerning tropomyosins have been made in neu-
rons both in vivo and in vitro (Gunning et al., 1998b), in fi-
broblasts (Lin et al., 1988), synchronized NIH3T3 cells
(Percival et al., 2000, 2004), epithelial cells (Temm-Grove
et al., 1998; Dalby-Payne et al., 2003), and Golgi-derived
vesicle fractions from rat liver (Heimann et al., 1999). Actin
isoform sorting has also been observed in skeletal muscle
(Prasad et al., 1993; Rybakova et al., 2000), smooth muscle
(North et al., 1994), and neurons (Weinberger et al., 1996).
Thus, the combination of isoform sorting and functional
differences between isoforms provides a potentially powerful
mechanism to segregate and independently regulate the
myriad functions of actin filaments.
Isoform sorting of actins in skeletal muscle suggests the
existence of a number of separate actin filament systems.
One system provides the thin filament component of the
sarcomere, which interdigitates with the myosin containing
thick filaments. The thin filaments, also known as sarco-
meric actin filaments, are composed of specific striated mus-
cle 
 
 
 
-actins and tropomyosins. A second filament system has
been detected with a 
 
 
 
-actin antibody. Staining for 
 
 
 
-actin
reveals its presence associated with costameres (Craig and
Pardo, 1983; Rybakova et al., 2000), mitochondria (Pardo
et al., 1983), and the Z-line (Nakata et al., 2001). This sug-
gests the possibility of a 
 
 
 
-actin containing filament system
that connects the myofibrils to the costameres.
We demonstrated previously that muscle differentiation is
accompanied by down-regulation of nonsarcomeric (NS)
tropomyosins and induction of muscle isoforms (Gunning
et al., 1990). It was noted, however, that some specific non-
muscle tropomyosins persist in adult muscle. We have used
our repertoire of tropomyosin antibodies to characterize
these isoforms in different adult skeletal muscles of the
mouse. Two spatially distinct populations of tropomyosin-
associated microfilaments are described: one in the sarco-
meric compartment and the other at the myofiber periph-
ery. Two tropomyosin isoforms, one (Tm5NM1) found in
all muscles and a second novel product from the 
 
 
 
-gene
(Tm5NM-34kd) found in a specific subset of muscles, local-
ized adjacent to the Z-line in longitudinal sections. Further
characterization of Tm localization in cross sections revealed
that these two tropomyosins reside in separate filament sys-
tems. Tm5NM1 is particularly concentrated at the myofiber
periphery and at lower amounts within the myofiber, pre-
sumably located between myofibrils. An anti–
 
 
 
-actin anti-
body colocalized with this nonmuscle Tm at the periphery
and within the fiber indicating that a 
 
 
 
-actin forms the
backbone of this filament system. The novel Tm isoform
Figure 1. Exon composition of tropomyosin (Tm) isoforms. The 
 -TM (A),  -TM (B), and  -TM (C) gene organization is shown, with 
boxes representing exons, lines introns, and unshaded parts of the 
exons untranslated regions. Homologous exons of the three genes 
are shown in the same shading pattern. Constitutive exons that are 
present in all known isoforms are represented by solid black boxes. 
A vertical bar and the letter A represent alternate polyadenylation 
sites. Antibodies used in this study with the specific exons they 
detect are shown in italics on the gene maps. All possible isoforms 
from the three genes are not depicted. The 311 antibody detects all 
isoforms containing exon 1a which includes sarcomeric ( Tmfast, 
 Tm, and  Tmslow) and NS Tms, and the  9d antibody detects 9d 
containing isoforms from the  -TM and  -TM genes. The  -TM 
gene-specific antibodies CG3 and  9d recognize isoforms containing 
exons 1b and 9d, respectively. 
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(Tm5NM-34kd) is located exclusively within the myofibers
and in a separate filament system which does not colocalize
with 
 
 
 
-actin. We have incorporated an inappropriate Tm
into the Z-line adjacent structure by overexpressing a high
molecular weight NS Tm, Tm3, that is not normally present
in muscle. This results in phenotypes in these mice that are
characteristic of muscular dystrophy and ragged-red fibers
(subsarcolemmal accumulation of mitochondria).
 
Results
 
NS Tms and NS actin are expressed in skeletal muscle
 
The large diversity of tropomyosin isoforms results from
multiple promoter initiation sites and extensive alternate
splicing from four genes (isoforms from three genes are
shown in Fig. 1). We and others have developed antibodies
that detect a large variety of NS tropomyosins from the TM
genes (Fig. 1). These antibodies were raised against peptides
encoded by specific exons, most of which recognize gene-
specific products (e.g., 
 
 
 
9d
 
). Using these antibodies, it has
been established in nonmuscle cells that the repertoire of
Tms expressed is both cell-type specific, and spatially segre-
gated within a cell (Lin et al., 1997; Gunning et al., 1998a,b).
We have previously observed that after muscle differenti-
ation, at least one mRNA encoding a cytoskeletal Tm from
the 
 
 
 
-TM gene persists in adult muscle. Antibodies directed
against the amino- (
 
CG3
 
) and carboxy-terminal (
 
 
 
9d
 
) exons
of the 
 
 
 
-TM gene were used to define protein expression
and location in adult muscle (Fig. 1).
Western blots reveal that adult skeletal muscles express
two NS Tms at significant levels (Fig. 2, A and B). The ex-
pression of NS Tms varies widely between different mus-
cles, with the extraocular muscle (EOM), soleus, and dia-
phragm muscles having particularly high levels of NS
Tms. A novel 34-kD muscle-specific isoform was detected
by the 
 
CG3
 
 antibody in these muscles (very low amounts
in flexor digitorum profundus muscle also; Fig. 2 A). All
known products recognized by 
 
CG3
 
 migrate at 30 kD
(e.g., Tm5NM1), therefore this is likely to be a larger pro-
tein with a novel carboxy terminus because it is not recog-
nized by the 
 
 
 
9d
 
 antibody (Fig. 2 B; no 34-kD band in
the Western blots) or antibodies against the other carboxy-
terminal exons from this gene (not depicted). In contrast
to the muscle-specific expression of this novel isoform,
 
 
 
9d
 
 detected a band that was present in all skeletal mus-
cles examined (Fig. 2 B). This band (30 kD) is likely to be
Tm5NM1, as a band of this size was not detected with an
antibody (WS5/9d; Percival et al., 2004) that preferen-
tially recognizes Tm5NM2, the only other exon 9d-con-
taining product from the 
 
 
 
-TM gene (Dufour et al.,
Figure 2. Expression of NS  -TM products and nonmuscle actins 
in skeletal muscles. Shown are representative Western blots of protein 
(10  g) from a range of mouse skeletal muscles and brain using anti-
bodies that detect NS Tms from the  -TM gene (A and B),  -actins 
(C), and  -actin (D). The CG3 antibody (A) specifically recognizes 
the  -TM 1b exon and detects all known NS products from this gene, 
whereas the  9d antibody (B) recognizes a subset of these NS Tms, 
those that contain exon 9d (Fig. 1 C). A novel Tm isoform was detected 
at high levels in a subset of the muscles examined (EOM, soleus, and 
diaphragm), a 34-kD protein from  -TM containing exon 1b (A, CG3 
antibody). This novel isoform has not been detected in nonmuscle 
tissues. Both  - and  -actin were detected in all muscles (C and D, 
respectively), but the levels were far greater for the former versus 
later isoforms. (Note that exposure to film was 45 s for  -actin vs. 20 
min for  -actin.) The  -actin antibody also detects  -smooth actin 
and so some of the signal with this antibody may be this isoform. 
(E) A representative Coomassie-stained gel used for the Westerns 
showing equal protein loading for the muscle extracts. Muscle 
abbreviations: ECU, extensor carpi ulnaris; EDL, extensor digitorum 
longus; EOM, extraocular muscles; FDP, flexor digitorum profundus; 
gastroc, gastrocnemius; quad, quadriceps; diaph, diaphragm.
Figure 3. Tm5NM-34kd is expressed in slow fibers, whereas the 
 9d isoforms are expressed in all major fiber types. Consecutive 
transverse sections (7  m) through the soleus muscle shows that 
fibers that were positive for the CG3 antibody (A and B, asterisks) 
were slow fibers (stained with the slow myosin heavy chain (MHC) 
antibody in B. Sections were stained with the primary antibodies 
followed by peroxidase-conjugated goat/anti–mouse secondary 
antibodies. In contrast to CG3,  9d stained all fibers in soleus (C) 
and EDL (E) muscles. Note that between them the soleus and EDL 
contain all adult skeletal muscle fiber types (types I, IIA, IIX, and 
IIB). Negative ( ve) control sections (D and F) with the secondary 
antibody (donkey anti–sheep Alexa 488) confirms the specificity 
of the staining with  9d. Bars, 40  m. 
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1998a). We have also examined the expression of nonmus-
cle actins that are known to be present in skeletal muscle,
 
 
 
-actin, and 
 
 
 
-actin (Fig. 2, C and D, respectively). 
 
 
 
-Actin
and 
 
 
 
-actin were expressed in all muscles examined, but
the level of expression of 
 
 
 
-actin was much greater than
 
 
 
-actin (Fig. 2, C and D, respectively). Because the 
 
 
 
-actin
antibody also detects 
 
 
 
-smooth actin (not depicted) we
cannot exclude the possibility that at least some of the
 
 
 
-actin signal is due to this isoform.
The novel CG3 isoform (Tm5NM-34kd) was expressed
at particularly high levels in the slow-twitch soleus muscle
and in other specialized muscles (Fig. 2 A, EOM and dia-
phragm). To examine fiber-type specific expression of this
isoform we stained serial transverse sections of soleus mus-
cles with 
 
CG3
 
 and a slow myosin heavy chain (MHC) anti-
body. Only slow fibers were strongly positive for 
 
CG3
 
 (Fig.
3, A and B) suggesting that Tm5NM-34kd is expressed
predominately in slow fibers in the soleus. High levels of
this novel Tm were also expressed in the diaphragm and
eye muscles (EOM), muscles that only have few (5–10%
of total) slow fibers in rodents (Wieczorek et al., 1985;
Seward et al., 2001) suggesting that Tm5NM-34kd may
also be expressed in fast fibers of the diaphragm and the
specialized fibers of the eye muscles (e.g., extraocular fast
and slow tonic in the EOM). In contrast, the 
 
 
 
9d
 
 anti-
body, which detects Tm5NM1 (Fig. 2 B), stained all fibers
of the soleus and extensor digitorum longus (EDL) muscles
(Fig. 3, C and E, respectively), indicating that Tm5NM1 is
in all adult skeletal muscle fibers (types I, IIA, IIX, and
IIB) in the mouse. This data is consistent with the Western
blots showing similar expression of Tm5NM1 in all mus-
cles (Fig. 2 B).
 
NS Tms define a novel Z-line adjacent compartment in 
skeletal muscle
 
Studies in a number of nonmuscle systems have shown that
the NS Tms are sorted to very specific intracellular loca-
tions (Gunning et al., 1998a,b). Therefore, we have stained
longitudinal sections of muscle with the 
 
 
 
9d and CG3
antibodies to define the localization of Tm5NM1 and
Tm5NM-34kd in muscle. Both antibodies produced strong
striated staining that was distinct from the thin filament
of the sarcomere. Specifically, both 
 
CG3
 
 and 
 
 
 
9d
 
 (Fig. 5,
A, D, and G, red staining) showed thin lines of staining ad-
jacent to the Z-line (Fig. 5, B and H, green 
 
 
 
-actinin stain-
ing) that did not correspond to the entire actin thin fila-
ment (Fig. 5 F, compare red 
 
CG3
 
 and green phalloidin/
filamentous-actin staining). The 
 
CG3
 
 and 
 
 
 
9d
 
 staining is
likely to represent the localization of Tm5NM-34kd and
Tm5NM1, respectively, as on Western blots these were the
predominant Tms detected by these antibodies in the so-
leus muscle (Fig. 2, A and B, respectively). On longitudinal
sections the two Tms colocalized with each other in this
Z-line adjacent region (Fig. 4 L, yellow staining in the
merged image) and both colocalized in this region with the
 
 
 
-actin antibody (Fig. 4, P–U). Costaining of sections with
antibodies to  -actin and the Z-line protein  -actinin indi-
cates that  -actin is at the Z-line adjacent region (Fig. 4 O)
and also at the Z-line itself (indicated by the colocalized
yellow signal of  -actin and  -actinin in Fig. 4 O). The NS
Tm banding pattern around the Z-line does not corre-
spond to any known pattern of Tm staining in skeletal myo-
fibers. Together, the data suggests that a  -actin and these
NS Tms are part of a novel cytoskeleton adjacent to the
Z-line.
Figure 4. The NS Tms from the  -gene and a  -actin are colocalized to a novel Z-line adjacent region of the sarcomere. Confocal immuno-
fluorescent images of semi-thin (0.5–1.0  m) longitudinal sections through adult soleus muscle show that Tms detected by CG3 and  9d (A, C, 
D, F, G, and I, red signal) are localized to a restricted area either side of Z-line (B, C, H, and I, delineated by the green  -actinin staining), but not 
including the Z-line. The restricted localization of these NS Tms to either side of the Z-line is in marked contrast to the broad region of the actin 
thin filament of the sarcomere (E and F, phalloidin). In longitudinal sections there appears to be little difference in the Z-line adjacent localization 
of the Tms detected by CG3 and  9d (J–L). Antibodies to a  -actin also stained the Z-line adjacent region (M–O) and this staining was coincident 
with the staining for both CG3 (P–R) and  9d (S–U). In some sections,  -actin staining was observed at the Z-line (M and O, arrowheads; R, inset). 
Double staining of muscle sections was performed by applying both the primary/secondary antibody pairs sequentially. Bars, 2.5  m.Novel cytoskeletal compartment in skeletal muscle | Kee et al. 689
The immunofluorescent microscopy on longitudinal sec-
tions indicated that the NS Tms recognized by CG3 and
 9d antibodies are present in a structure that exists adjacent
to the Z-line. To gain more information about this struc-
ture we stained transverse sections of soleus muscle with
these two antibodies and costained with the Z-line marker,
 -actinin (Fig. 5, A–F). From the merged images it is evi-
dent that the pattern of staining of  9d and CG3 is separate
from  -actinin (Fig. 5, C and F, respectively); the green and
red signals do not overlap for the most part. As  -actinin
stains the Z-line within individual myofibrils these images
suggest that Tm5NM1 and the novel 34-kD Tm are likely
to be part of microfilaments not closely associated with the
myofibrils. Moreover, the Tms recognized by CG3 and  9d
appear to be part of separate filament systems as there was
little colocalized signal with these antibodies on merged im-
ages (Fig. 5 I). Although  9d (Tm5NM1) stained areas
within the myofiber, the strongest staining for this antibody
was at the myofiber periphery (Fig. 5, A and K). However,
 9d staining did not coincide with dystrophin, a classical
membrane marker, but rather stained the subsarcolemmal
space in a discontinuous fashion (Fig. 5 L, inset).
We next stained transverse sections of soleus muscle with
the  -actin antibody and the NS Tm antibodies to determine
whether a  -actin is part of the novel NS Tm filament struc-
ture in muscle (Fig. 6). From the merged images it is evident
that there is almost complete colocalization of  9d and  -actin
both within the myofiber and at the fiber periphery (Fig. 6 C).
In contrast, the staining of CG3 appeared to be separate from
 -actin (Fig. 6 F, inset). This suggests that in skeletal muscle
Tm5NM1 (detected by  9d) is part of a  -actin filament net-
work, whereas the novel CG3 Tm (Tm5NM-34kd) associates
with a different actin filament system.  -Actin staining was
not coincident with  -actinin (Fig. 6 I) and was concentrated
in the subsarcolemmal space separate from dystrophin (Fig. 6
L). This pattern of staining is similar to  9d and is consistent
with a  -actin–Tm5NM1 filament system located between
the myofibrils and in the subsarcolemmal space.
Figure 5. NS Tms recognized by the CG3 and  9d antibodies 
have distinct myofiber localization. Shown are confocal images of 
transverse sections (7  m) through soleus muscles stained with  9d 
(A) or CG3 (D) and costained with  -actinin (B and E). The enlarged 
merged images (C and F, insets) indicate that the Tms recognized by 
 9d and CG3 are not colocalized with  -actinin (labels myofibrils) 
and therefore are located outside the myofibrils. Further transverse 
sections (G–I) show that CG3 and  9d stain separate regions within 
the myofiber (particularly notable in the enlarged inset, I). Cross 
sections costained with the membrane protein dystrophin (J) and 
 9d (K) also show strong staining of  9d at the myofiber periphery 
beneath the membrane (L, arrow in the enlarged inset). Bars, 20  m.
Figure 6.  In transverse section, the  9d Tms localize with a  -actin, 
whereas the CG3 Tms do not. Shown are confocal images of trans-
verse sections (7  m) through soleus muscles stained with  9d (A) 
or CG3 (D) and costained with a  -actin antibody (B and E). The 
merged images show that the Tms recognized by  9d colocalize 
with a  -actin within the myofiber and at the fiber periphery (C), 
whereas the CG3 Tms are not localized with  -actin (F). In addition, 
signal for a  -actin did not coincide with  -actinin (I, enlarged inset) 
indicating that  -actin microfilaments are not closely associated 
with the myofibrils. The most intense  -actin staining was at the 
myofiber periphery (B, E, H, and K), but the staining was mostly distinct 
from the sarcolemmal staining of dystrophin (L, inset). Bars, 20  m.690 The Journal of Cell Biology | Volume 166, Number 5, 2004
An ectopic NS Tm, Tm3, incorporates into the Z-line 
adjacent structure
As the NS Tms appear to be part of different cytoskeletal
structures in muscle we were interested to examine what
effect the expression of an inappropriate cytoskeletal Tm
would have on the Tms defining these structures. Therefore,
we have studied transgenic mice that express an NS Tm,
Tm3, that is not normally expressed in skeletal muscle (Fig.
7 A). Western blots with the  9d antibody, show that trans-
genic lines 3/66 and 3/70 accumulate very high levels of
Tm3 in a wide range of muscles (Fig. 7 A). Tm3 is also de-
tected by  9d in the transgenic mice (Fig. 7 A), as there is
some cross-reactivity of the antibody to exon 9d from the  -
and  -TM genes.
The levels of NS Tm3 in the transgenic mice do not,
however, exceed that of the muscle sarcomeric Tms (Fig. 7
B). A Western blot of quadriceps muscle from control WT
and line 3/66 mice probed with an antibody (311) to exon
1a of the  -,  -, and  -TM genes is shown in Fig. 7 B. Strong
bands corresponding to the sarcomeric Tms ( Tmslow,  Tmfast,
and  Tm) are evident in both control and 3/66 muscles. In
addition, a band corresponding to Tm3 is seen migrating
slightly faster than  -Tm. Thus, the levels of Tm3 in these
mice approach that of the sarcomeric Tms and there is no
indication of a compensating down-regulation of the sarco-
meric isoforms.
Examination of Western blots probed with the  9d,  9d,
and  CG3 antibodies (Fig. 7 A) shows that expression of
Tm3 in skeletal muscle has little effect on the expression of
many other NS Tms (e.g., Tm1, Tm2, and Tm6). The only
exception appears to be increased expression of the novel
Tm5NM-34kd CG3 isoform in the flexor digitorum pro-
fundus muscle (Fig. 7 A).
The ectopic Tm3 protein localized to the same Z-line
adjacent region as the endogenous  -TM gene isoforms
(Tm5NM1 and Tm5NM-34kd; Fig. 8). Very strong stain-
ing either side of the Z-line can be seen in soleus longitudi-
nal sections with the  9d antibody (Fig. 8, A and C). Ec-
topic Tm3 was mainly restricted to the cytoplasmic region
of the myofiber (Fig. 8, G, K, and L). This staining is spe-
cific for ectopic Tm3 as although this antibody detects a
number of different endogenous isoforms in the soleus mus-
cle (Fig. 7 A) none of these are present in the cytoplasmic
sarcomeric regions of the muscle (Fig. 8, D and J). In longi-
tudinal and cross sections, ectopic Tm3 colocalized with the
 -actin antibody (Fig. 8, I and N, respectively). This is con-
sistent with an association of Tm3 with a Z-line adjacent
 -actin cytoskeleton.
Figure 7. Expression of high levels of Tm3 in muscle has little effect 
on expression of sarcomeric and NS Tms. Western blots of 6-mo-old 
Tm3 skeletal muscle showing the influence of high levels of Tm3 
expression on (A) NS or (B) sarcomeric Tm isoforms. Results for both 
wild-type (WT) and high-expressing transgenic lines (3/70 and 3/66) 
are shown. NS Tms containing exon 9d from the  - and  -TM genes 
are recognized by  9d. Products containing exon 1b and exon 9d 
from the  -TM gene are recognized by CG3 and  9d, respectively. 
A Tm3 band is detected by the  9d antibody in Tm3 mice (3/70 and 
3/66) due to cross-reactivity of the antibody with exon 9d products 
from the  -TM gene. The 311 antibody recognizes Tms containing 
exon 1a (Fig. 1), which includes Tm3 and the three sarcomeric Tms 
( Tmfast,  Tmslow, and  Tm). Under the electrophoretic conditions 
used the  Tmfast and  Tmslow isoforms are seen as a single band. 
See Fig. 2 legend for muscle abbreviations.
Figure 8. Ectopically expressed Tm3 accumulates adjacent to the 
Z-line and at the M-line. Shown are immunofluorescent confocal 
images of longitudinal and transverse sections of soleus muscle from 
adult Tm3 transgenic (line 3/66) and wild-type (WT) mice. WT soleus 
muscle contains two main Tm isoforms (Tm1 and Tm6; Fig. 7 A) 
recognized by the  9d antibody. Longitudinal and transverse sections 
(7  m) of WT muscle indicate that these isoforms are present in 
structures outside of the myofiber and at the myofiber periphery 
(D and J, respectively). Tm3 (also detected by the  9d antibody; 
Fig. 1 A), is absent from WT muscle (Fig. 7 A), but in the Tm3 mice 
the ectopic protein is located at the Z-line adjacent region (A–C, 
0.5–1.0  m longitudinal sections; Z-line marked by arrows) and 
at the M-line (A and C, arrowheads). Tm3 localized mainly to the 
sarcomeric compartment (G and K) and was colocalized with the 
 -actin antibody in longitudinal and cross sections (I and N, respec-
tively). Bars: (A–C) 2.5  m; (D–I) 40  m; and (J–N) 20  m.Novel cytoskeletal compartment in skeletal muscle | Kee et al. 691
Tm3 expression elicits a dystrophic and ragged-red 
fiber phenotype
We next examined the effect of expression of Tm3 on
muscle pathology (Fig. 9). Muscles from Tm3 mice showed
classical signs of muscular dystrophy as visualized by he-
matoxylin and eosin (H&E) staining of cross sections.
This includes large areas of myofiber degeneration, mac-
rophage infiltration and fibrosis and regions of small re-
generating fibers with centralized nuclei (Fig. 9, B, C, and
F). Dystrophic features were observed in both transgenic
lines (3/66 and 3/70) and in a number of different mus-
cles: the quadriceps (Fig. 9, B and C), soleus (Fig. 9 F),
gastrocnemius, and back muscles (results not depicted for
latter two sets of muscles).
Further histological examination showed that the Tm3
mice also have ragged-red fibers (Fig. 9, E and H). Ragged-
red fibers are not normally associated with dystrophies
but are a common feature of mitochondrial myopathies
(Banker and Engel, 1994). Dark submembranous staining
was clearly evident in Gomori-Trichrome (Fig. 9 H) and H&E
stained sections (Fig. 9 E) from Tm3 mice. On EM exami-
nation this was shown to be an abnormally large accumula-
Figure 9. Inappropriate expression of an NS Tm (Tm3) results in muscular dystrophy phenotype and ragged-red fibers. The Tm3 mice have 
a number of features characteristic of muscular dystrophy in quadriceps (A–C) and soleus muscles (D–F). Features characteristic of muscular 
dystrophy shown in H&E stained transverse sections (A–F) include: areas of regenerating fibers with centralized nuclei (B, C, and F, black arrows), 
myofiber size variability (B, C, and F), and regions of fiber degeneration (F, white arrow), macrophage infiltration (B and F, black double arrows) 
and fibrosis (F, white arrowhead). Soleus muscle from Tm3 mice also has the characteristic accumulation of sarcolemmal mitochondria that 
is associated with ragged red fibers. Mitochondrial accumulations (black arrowheads) were observed in Gomori-Trichrome (G) and H&E stained 
(E) sections in of soleus of line 3/66 mice. The large increase in number and size of mitochondria beneath the sarcolemma is clearly evident in 
electron micrographs from Tm3 mice (J) compared with WT mice (I). Asterisks in I and J mark the subsarcolemmal mitochondria. Bars, A–H, 
40  m. When suspended by the tail the Tm3 mice (line 3/66; L), unlike the WT mice (K), are unable to extend their hindlimbs away from the 
body. This phenomenon has been observed in a mouse model of muscular dystrophy (Bittner et al., 1999).692 The Journal of Cell Biology | Volume 166, Number 5, 2004
tion of mitochondria beneath the sarcolemma in Tm3/66
compared with WT mice (Fig. 9, J vs. I, respectively). The
mitochondria were large in size and number, but the inter-
nal structure of the mitochondria appeared to be normal, as
did the morphology of the inter-myofibrillar mitochondria.
The dystrophic features were associated with muscle
weakness that is shown by the inability of the Tm3 mice to
extend their limbs when held by the tail (compare WT and
Tm3/66 mice in Fig. 9, K and L, respectively). This type of
muscle dysfunction is similar to that observed in SJL mice,
a natural mouse model for limb girdle muscular dystrophy
2B (Bittner et al., 1999). The Tm3 mice also have altered
gait when running on a treadmill; they run with their hind-
limbs closer to the body and with an arched back. Further
evidence of dystrophy in the Tm3 mice is the raised levels
of serum creatine kinase (1300   150 U/L [mean   SEM]
and 300   50 U/L for Tm3 [n   5] and WT [n   4] mice,
respectively; P   0.023, ANOVA). Elevated plasma cre-
atine kinase is a characteristic feature of muscular dystrophies
and is thought to be an indicator of loss of sarcolemma in-
tegrity. Therefore, we conclude that incorporation of Tm3
into the novel Z-line–associated actin–Tm filament net-
work leads to mice with features of muscular dystrophy and
ragged-red fiber myopathy.
Discussion
NS tropomyosin isoforms are expressed in skeletal muscle
There is increasing evidence for the existence of a cytoskeleton
spatially separated from the contractile apparatus in skeletal
muscle (Clark et al., 2002; Ervasti, 2003).  -Actin is enriched
in the cytoskeleton associated with the postsynaptic folds of
the neuromuscular junction (Hall et al., 1981; Lubit, 1984).
In contrast,  -actin is found in microfilaments associated with
dystrophin at the costameres (Rybakova et al., 2000; Ervasti,
2003).  -Actin is also detected in a structure which coaligns
with  -actinin (Nakata et al., 2001) and associates with sub-
sarcolemmal mitochondria as well (Pardo et al., 1983).
Previously, we found that during muscle differentiation
there is a switch in Tm expression from NS to sarcomeric
isoforms (Gunning et al., 1990). However, expression of a
number of NS isoforms, particularly from the  - and  -TM
genes, persisted in adult muscle. The more detailed analysis
shown here using isoform specific antibodies demonstrates
that the level of NS Tm expression is highly muscle specific.
In addition to the known cytoskeletal Tm (Tm5NM1) that
was expressed in all muscles, skeletal muscle also expresses a
novel 34-kD product recognized by CG3 that was abundant
in a very restricted set of muscles, the EOM, the diaphragm,
and the soleus muscle. There is no known EST correspond-
ing to the novel  -TM 34-kD product, although we have
previously reported a novel, slow muscle specific transcript
from this gene (Dufour et al., 1998b). The carboxy terminus
of this product has not been characterized but may corre-
spond to this novel 34-kD product.
The novel Tm5NM-34-kD protein, a product of the
 -TM gene, is abundant in slow fibers, but appears not to
be restricted to slow fibers because it is abundant in muscles
that contain few slow fibers (EOM and diaphragm). This
unusual pattern of expression suggests this isoform has some
specialized function in specific myofibers in contrast to
Tm5NM1, which is expressed in all muscle fibers. The mus-
cles that contain high amounts of the novel Tm are char-
acterized by chronic or frequent contractions. This sug-
gests that Tm5NM-34kd may be associated with a structure
unique to these fibers.
Figure 10. Schematic representation of NS Tm localization in 
skeletal muscle. Depicted are myofibers in longitudinal (A) and 
transverse section (B) showing the location of the NS Tms and  -actin 
in relation to the major structures in skeletal muscle. (A) In the longi-
tudinal representation, two main membrane/cytoskeletal junctions 
are depicted: (1) integrin-based focal adhesions and (2) the dystrophin 
glycoprotein complex. Hypothesized tropomyosin-associated  -actin 
networks that link the sarcomeric arrays to the costamere are shown 
as black lines. Other filaments linking the M-line and Z-line to the 
membrane are not depicted. The results of this study suggest that 
the NS tropomyosins recognized by the  9d and CG3 antibodies 
(Tm5NM1 and Tm5NM-34kd, respectively) are located adjacent to 
the Z-line in the sarcomeric space. Data suggest that Tm5NM1 asso-
ciates with a  -actin whereas the actin (broken black line) interacting 
with Tm5NM-34kd was not defined. Note that although  -actinin 
(pink) is only shown cross-linking  -actin filaments, its main location 
is in the Z-line linking sarcomeric actin thin filaments from adjacent 
sarcomeres. (B) In the transverse representation, Tm5NM1 (blue) and 
Tm5NM-34kd (green) are shown in the intermyofibrillar space, the 
former in association with a  -actin and the later with an unknown 
actin filament system. Also shown is Tm5NM1/ -actin filaments at 
the subsarcolemmal region, a space also occupied by mitochondria. 
The data suggests that the Tm5NM1 filaments are in all adult fibers, 
whereas the Tm5NM-34kd structure is restricted to specialized subset 
of fibers. The ectopic Tm3 localizes to the Z-line–associated  -actin 
cytoskeleton and results in muscular dystrophy and ragged-red fibers.Novel cytoskeletal compartment in skeletal muscle | Kee et al. 693
Tropomyosin isoforms define a novel Z-line–associated 
element in skeletal muscle
Using antibodies to  -TM gene products ( 9d and CG3)
and an antibody to a  -actin, a novel structural compart-
ment in muscle has been identified. This compartment is
present at a very restricted area adjacent to the Z-line. Analy-
sis of muscle transverse sections suggests that within this
compartment there are at least two separate structures lo-
cated in the intermyofibrillar space. One, labeled by  9d,
containing Tm5NM1, appears to be associated with a
 -actin filament network, and the other, defined by CG3
(Tm5NM-34kd), appears to be part of a separate filament
system. The localization of Tm5NM1 and Tm5NM-34kd
in the intermyofibrillar space aligned adjacent to the Z-line
suggests there are filament networks that laterally intercon-
nects the Z-line adjacent region of individual myofibrils
(Fig. 10 A). This system would be analogous to the desmin
intermediate filament network that laterally interlinks the
Z-disks of each myofibril (Capetanaki, 2002).
A subsarcolemmal filament system containing Tm5NM1
(labeled by  9d) and a  -actin was also identified. These fil-
aments were not evenly distributed around the periphery of
the myofiber but were concentrated in discrete foci near the
membrane and often extended some distance into the myo-
fiber. Previous studies have shown association of  -actin
with the subsarcolemmal mitochondria (Pardo et al., 1983).
Thus, the present findings are consistent with Tm5NM1 be-
ing part of this  -actin cytoskeleton (Fig. 10 B).
There is increasing evidence that many signaling molecules
are present in a region adjacent to the Z-line in skeletal muscle
(Ervasti, 2003). Chisel, STARS, Arpp, myopalladin, enigma,
FHL3, and myopodin locate to this region in skeletal muscle
(Guy et al., 1999; Bang et al., 2001; Palmer et al., 2001; Arai
et al., 2002; Tsukamoto et al., 2002; Coghill et al., 2003).
The colocalization of these molecules suggests that there must
be a scaffold that provides the structure to organize these mol-
ecules. This provides evidence for a structural network of sig-
naling molecules that links the sarcomere to costameres and
the ECM. The NS Tm–actin filament network described in
the present investigation may be such a scaffold structure.
Incorporation of Tm3 into Z-LAC results in muscular 
dystrophy and ragged-red fibers
Transgenic mice that express Tm3 in their skeletal muscle
display two significant pathologies. Because the Tm3 is
specifically targeted to the Z-line–associated cytoskeleton,
we propose that it is the inclusion of Tm3 into this struc-
ture which directly leads to the pathologies. The patholo-
gies and localization were observed in two independent
transgenic lines indicating that these pathologies are not
due to transgene integration-site effects. The impact of
Tm3 does not appear to be due to competing the endoge-
nous Tms out of this structure because CG3 and  9d stain-
ing is unchanged (unpublished data) and the levels of
Tm5NM1 and Tm5NM-34kd are unchanged. This sug-
gests that the  -actin filaments that presumably provide
the backbone for these microfilaments are not saturated
with tropomyosin and can accommodate the ectopic ex-
pression of Tm3. This may also account for the specific
sorting of Tm3 to this site because these  -actin filaments
may be the major source of microfilaments lacking tro-
pomyosin in skeletal muscle.
Mutations in a growing number of costameric proteins
and proteins that interact with the costamere have been
identified as causes of muscular dystrophies (Ervasti, 2003).
The best-known example is dystrophin itself, which leads
to dystrophies of differing severity depending on the spe-
cific mutations (Dalkilic and Kunkel, 2003). Recently, pro-
teins that interact with the Z-line have also been shown to
cause muscular dystrophies when mutated or absent (e.g.,
telethonin, calpain 3; Richard et al., 1995; Moreira et al.,
2000). This suggests that it is a defect in the overall func-
tion of this complex that is responsible for the majority of
dystrophies. The muscles of Tm3 transgenic mice display a
phenotype characteristic of muscular dystrophy. Because
Tm3 specifically localizes to the Z-line adjacent microfila-
ments, the data suggest that it is dysfunction of these fila-
ments resulting from inappropriately targeted Tm3 that is
leading to the dystrophic phenotype. Furthermore, this
provides evidence that this microfilament network is an im-
portant structural element that directly or indirectly links
the sarcomere to the sarcolemma, and that mutations in
this structure may account for some currently unknown
causes of muscular dystrophy.
The appearance of ragged-red fibers in the Tm3 trans-
genic lines suggests that the NS Tm cytoskeletal structures
may influence mitochondrial function. It is notable that the
desmin knockout mouse displays a similar mitochondria
phenotype (Milner et al., 2000). Mitochondria are normally
located beneath the sarcolemma and also near the Z-line be-
tween myofibrils. Previous studies have shown an associa-
tion of  -actin with subsarcolemmal mitochondria (Pardo et
al., 1983; Nakata et al., 2001) and the present results are
consistent with NS Tms (Tm5NM1) associated with these
microfilaments. It is possible that the  -actin Z-line–associ-
ated cytoskeleton and desmin play a role in anchoring mito-
chondria at this site. Disruption of this anchoring may leads
to mitochondrial disruption on the one hand and migration
to the cell periphery on the other.
In conclusion, the novel NS microfilament structure, to-
gether with desmin, may provide a physical link between
the myofibrils, the costamere and the ECM. Alterations in
the function of this novel structure may lead to muscular
dystrophy and/or ragged-red fibers. The tropomyosin com-
ponents of this Z-line–associated cytoskeleton should now
be included as candidate genes in searches for mutations
that cause these diseases.
Materials and methods
Generation of the Tropomyosin-3 (Tm3) transgenic mouse
The rat Tm3 cDNA under the control of the human  -actin promoter was
removed from vector sequences with Kpn1 and EcoR1 (Roche Diagnos-
tics). The amino acid sequence for human, rat, and mouse Tm3 are identi-
cal. Fertilized eggs were collected from superovulated FVB/NJ females, in-
jected with the DNA, and transferred to pseudopregnant females according
to Hogan et al. (1994). Transgenic mice were screened by Southern blot of
DNA from mice tails, digested with SacI (Roche Diagnostics, Inc.), and
probed with a 1-kb SacI fragment from the 5  flanking region of the  -actin
promoter. Wild-type mice were nontransgenic FVB/NJ littermates. The
CMRI/CHW Animal Care and Ethics Committee approved this study.694 The Journal of Cell Biology | Volume 166, Number 5, 2004
Immunohistochemistry
Standard cryosectioning. Immediately after dissection, mouse muscles were
coated in tissue freezing medium (Tissue-Tek O.C.T., ProSciTech), frozen
in melting isopentane prechilled in liquid nitrogen and stored at  80 C.
Muscles were sectioned in a cryostat microtome (HM500OM; Carl Zeiss
MicroImaging, Inc.) at 7  m, fixed in cold 2% PFA, and washed in PBS.
Semi-thin sectioning.  Greater resolution of Z-line–associated structures
was achieved with semi-thin (0.5–1.0  m) longitudinal sections of maxi-
mally stretched muscle (50% greater than the resting muscle length). Im-
mediately after dissection, the muscle was stretched and fixed in 4% form-
aldehyde for 30 min at 4 C and processed for cryoultramicrotomy as
described by Griffiths et al. (1984) with modification. In brief, after fixa-
tion, muscles were cut into small strips (4–5-mm long   1-mm wide) and
transferred to 1.8 M sucrose/17% polyvinylpyrrolidone for overnight infu-
sion. Muscle strips were trimmed further, mounted on cryopins, and snap-
frozen in liquid nitrogen. Semi-thin (0.5–1.0  m) sections were cut at
 60 C using an Ultracut UCT ultramicrotome (Leica) equipped with an
EM FCS cryochamber (Leica). Sections were suspended in 2.3 M sucrose,
allowed to thaw, and placed on poly-O-lysine coated slides (Starfrost).
Immunostaining. Both thick (7  m) and semi-thin (0.5–1.0  m) sections
were blocked overnight (4 C) in PBS Triton X-100 (0.05%) containing
0.2% fish gelatin and 2% BSA. The primary antibodies were applied for
60–90 min at RT, slides were washed with PBS, and secondary antibody
was applied (60–90 min at RT). Double staining was performed by apply-
ing primary/secondary antibody pairs sequentially, i.e., the first primary
and its secondary and then the second primary and its secondary. After
washing to remove unbound secondary antibody, slides were mounted
with Vectashield (Vector Laboratories) and viewed using a confocal laser
scanning microscope (model TCS SP2; Leica) with an oil immersion 63 
objective and analyzed with confocal software (Leica).
Antibodies
The polyclonal antibodies  9d and  9d were directed against the exon 9d
of the  - and  -TM genes, respectively. The  9d antibody is a polyclonal
sheep antibody and detects isoforms Tm5NM1 and Tm5NM2 (Percival et
al., 2004; Fig. 1 C), whereas  9d (originally WS /9d) is a polyclonal anti-
body that detects Tm2, Tm3, Tm5a, Tm5b, and Tm6 from the  -TM gene
and Tm1 from the  -TM gene (Schevzov et al., 1997; Fig. 1, A and B). Ei-
ther a polyclonal rabbit or sheep  9d antibody was used depending on the
species of the costaining antibody. CG3 is a mouse monoclonal that recog-
nizes exon 1b of the  -TM gene and detects all NS products (Fig. 1 C; Lin
et al., 1988). The affinity purified  -actin antibody is a polyclonal sheep
antibody raised against the first 14 aa of cytoplasmic  -actin (EEEIAALVID-
NGSG). The commercially available mouse monoclonal 311 Tm antibody
(Sigma-Aldrich), which recognizes Tms containing exon 1a sequence from
the  -,  -, and  -TM genes, was used. The  -actinin-2 antibody was a rab-
bit polyclonal antiserum was provided by A. Beggs (Children’s Hospital,
Boston, MA; North and Beggs, 1996). A rabbit polyclonal antibody recog-
nizing the rod domain of dystrophin (Dys6-10) was provided by L. Kunkel
(Children’s Hospital). Slow fibers were detected with mAbs to the slow
MHC isoform (undiluted BA-F8; Sigma-Aldrich) obtained from superna-
tants of hybridoma cultures (Borrione et al., 1988). Double staining with
TRITC-labeled phalloidin (Sigma-Aldrich) was performed after the applica-
tion of the primary antibody.
The following commercially available secondary antibodies were used:
donkey anti–mouse HRP (Amersham Biosciences); donkey anti–rabbit
HRP (Amersham Biosciences); donkey anti–sheep HRP (Jackson Immu-
noResearch Laboratories); goat anti–rabbit FITC-labeled IgG (Sigma-
Aldrich); goat anti–mouse Cy3 (Jackson ImmunoResearch Laboratories);
and goat anti–rabbit Cy3 (Jackson ImmunoResearch Laboratories). The fol-
lowing Alexa-conjugated antibodies were also used (Molecular Probes):
donkey anti–mouse IgG (L   H) Alexa 488; donkey anti–sheep IgG Alexa
488 and 555; goat anti–mouse IgM Alexa 488; goat anti–mouse IgG Alexa
488; and goat anti–rabbit IgG Alexa 488 and 555. All secondary antibod-
ies were used at a 1:1,000 dilution.
Histopathological analysis
Mouse muscles were frozen as described above for immunohistochemis-
try. Sections were placed on poly-L-lysine precoated glass microscope
slides, air dried, and stained with H&E or the modified Gomori-Trichrome
method (Engel and Cunningham, 1963).
EM
Muscles were removed immediately after euthanasia and cut into very thin
slices while immersed in modified Karnovski’s fixative (2.5% glutaralde-
hyde/4% PFA in 1 M cacodylate buffer, pH 7.4). Samples were further
fixed overnight in the same fixative and fixed after with 2% osmium tetrox-
ide, dehydrated through an ascending series of ethanol, and embedded in
Spurr’s epoxy resin. Ultrathin sections were cut with a Reichert-Jung Ul-
tracut ultramicrotome, double contrasted with uranyl acetate and lead ci-
trate, and viewed and photographed with a BioTwin transmission electron
microscope (model CM120; Philips).
Western blot analysis
Skeletal muscle tissue was homogenized in 20 vol of 10 mM Tris, pH 7.6/
2% SDS/20 mM DTT by boiling followed by crushing with a pestle in a mi-
crotube. The samples were then solubilized by gentle sonication, boiled
again, and spun at 12,000 rpm to remove insoluble particles. An equal
volume of SDS-PAGE sample buffer (4% SDS, 12% glycerol, 2% mercap-
toethanol, 0.01% Coomassie G-250, 50 mM Tris-Cl, pH 6.8) was added
and the sample stored at  20 C. Equal volumes of protein (10  g) were
analyzed on 15% SDS-PAGE (with low 0.9% bis-acrylamide) gels with ref-
erence to a standard known amount of brain protein previously deter-
mined using a BCA protein assay kit (Pierce Chemical Co.) and volumes
adjusted where necessary. Coomassie-stained gels were used to verify
equal loading. Protein was transferred onto PVDF membranes (Millipore)
at 80 V at 4 C. Blots were blocked in 5% skim milk at 4 C, washed in TBS,
and incubated with the antibodies for 2 h at RT followed by three washes
with TBS 0.05% Tween 20. HRP-labeled secondary antibody was added at
1:10,000 dilution for 1 h at RT. Excess antibody was removed with 4   20
min washes. Detection was performed using the Western lightning chemi-
luminescence detection system (PerkinElmer) on Biomax X-ray film (Ko-
dak) for varying times (2–60 min).
Serum creatine kinase measurement
Blood was taken from 6-mo-old anesthetized (halothane) WT and Tm3 mice
by cardiac puncture. Serum creatine kinase was measured using a commer-
cial kit and a serum quality control sample (Trace/DMA; Thermo Electron).
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